As for other predictive models in HCC, Luo, et al. [25] constructed a 5-gene (NET1, ATP6V0B, MMP1, GTDC1, and CPEB3) risk model through LASSO analyses for predicting immunotherapy response. This evidence concerns the gene NET1 and hepatocellular carcinoma.